Post-COVID-19 Impairment of the Senses of Smell, Taste, Hearing, and Balance.
COVID-19
SARS-CoV-2
neurological disorders
sensory system
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
20 04 2022
20 04 2022
Historique:
received:
02
03
2022
revised:
01
04
2022
accepted:
18
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
1
6
2022
Statut:
epublish
Résumé
Various symptoms have been associated with COVID-19, but little is known about the impacts of COVID-19 on the sensory system, risk factors, and the duration of symptoms. This study assesses olfactory, gustatory, hearing, and vestibular systems after COVID-19. This cross-sectional, single-center study involved 50 patients one to six months after COVID-19 and reports their patient records and the extent, onset, and duration of olfactory, gustatory, hearing, and balance disorders using questionnaires during and after COVID-19. Sensory symptoms were objectively studied using the following clinical tests after COVID-19 Sniffin' Sticks, taste tests, tone/speech audiometry, and video head impulse test. Post-COVID-19-patients were suffering from olfactory and gustatory impairment for up to six months. According to the Dizziness Handicap Inventory, balance disorders were less noticed: Overall, about 40% of the patients during COVID-19 and nearly all patients recovered within six months. After COVID-19, clinical tests revealed that 75% were suffering from hyposomnia/anosmia, and 20% of all patients reported mild hypogeusia for up to six months. Vestibular disorders and hearing impairment rarely/did not occur. Females were significantly more affected by sensory impairments than males. COVID-19 particularly caused olfactory and gustatory impairment; balance disorders were present too; vestibular and auditory symptoms were negligible.
Sections du résumé
BACKGROUND
Various symptoms have been associated with COVID-19, but little is known about the impacts of COVID-19 on the sensory system, risk factors, and the duration of symptoms. This study assesses olfactory, gustatory, hearing, and vestibular systems after COVID-19.
METHODS
This cross-sectional, single-center study involved 50 patients one to six months after COVID-19 and reports their patient records and the extent, onset, and duration of olfactory, gustatory, hearing, and balance disorders using questionnaires during and after COVID-19. Sensory symptoms were objectively studied using the following clinical tests after COVID-19 Sniffin' Sticks, taste tests, tone/speech audiometry, and video head impulse test.
RESULTS
Post-COVID-19-patients were suffering from olfactory and gustatory impairment for up to six months. According to the Dizziness Handicap Inventory, balance disorders were less noticed: Overall, about 40% of the patients during COVID-19 and nearly all patients recovered within six months. After COVID-19, clinical tests revealed that 75% were suffering from hyposomnia/anosmia, and 20% of all patients reported mild hypogeusia for up to six months. Vestibular disorders and hearing impairment rarely/did not occur. Females were significantly more affected by sensory impairments than males.
CONCLUSIONS
COVID-19 particularly caused olfactory and gustatory impairment; balance disorders were present too; vestibular and auditory symptoms were negligible.
Identifiants
pubmed: 35632590
pii: v14050849
doi: 10.3390/v14050849
pmc: PMC9145380
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Clin Microbiol Infect. 2020 Jul;26(7):948.e1-948.e3
pubmed: 32360780
Cell. 2020 Oct 1;183(1):16-27.e1
pubmed: 32882182
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Otol Neurotol. 2021 Jan;42(1):e10-e14
pubmed: 33301283
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
Eur Arch Otorhinolaryngol. 2019 Mar;276(3):719-728
pubmed: 30554358
J Anxiety Disord. 2001 Jan-Apr;15(1-2):9-26
pubmed: 11388360
Front Neurol. 2020 May 22;11:518
pubmed: 32574248
J Med Virol. 2020 Jun;92(6):577-583
pubmed: 32162702
Brain Behav Immun. 2020 Oct;89:579-586
pubmed: 32629042
BMJ. 2021 Dec 16;375:n3103
pubmed: 34916215
J Clin Med. 2022 Jan 14;11(2):
pubmed: 35054108
Front Neurol. 2013 Mar 22;4:29
pubmed: 23526567
Cureus. 2020 Jun 30;12(6):e8918
pubmed: 32760619
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Rhinology. 2020 Aug 1;58(4):404-405
pubmed: 32533768
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915975
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
Nat Commun. 2020 Oct 14;11(1):5152
pubmed: 33056983
Arch Otolaryngol Head Neck Surg. 1990 Apr;116(4):424-7
pubmed: 2317323
Otol Neurotol. 2018 Dec;39(10):e1111-e1117
pubmed: 30303945
JAMA. 1975 Aug 11;233(6):527-30
pubmed: 167209
Cell Death Discov. 2021 Apr 13;7(1):77
pubmed: 33850105
Neuroscience. 1979;4(6):713-27
pubmed: 481748
J Clin Med. 2021 Mar 02;10(5):
pubmed: 33801170
J Otol. 2021 Jul;16(3):158-164
pubmed: 33558808
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
Nat Neurosci. 2021 Feb;24(2):168-175
pubmed: 33257876
Infect Dis (Lond). 2021 Oct;53(10):737-754
pubmed: 34024217
J Cell Biol. 1965 Nov;27(2):263-72
pubmed: 5884625
J Virol. 2010 Dec;84(24):12658-64
pubmed: 20926566
Crit Care. 2020 Jan 6;24(1):5
pubmed: 31907011
Am J Otolaryngol. 2020 Sep - Oct;41(5):102612
pubmed: 32574896
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Chem Senses. 1997 Feb;22(1):39-52
pubmed: 9056084
BMJ Case Rep. 2020 Oct 13;13(11):
pubmed: 33051251
EClinicalMedicine. 2021 May 24;36:100899
pubmed: 34036253
J Mol Neurosci. 2021 Nov;71(11):2192-2209
pubmed: 33464535
Laryngoscope. 2021 May;131(5):1095-1100
pubmed: 33404079
Ann N Y Acad Sci. 2009 Jul;1170:596-603
pubmed: 19686199
ORL J Otorhinolaryngol Relat Spec. 2020;82(6):295-303
pubmed: 33049753
Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):691-697
pubmed: 33033955
Neurology. 2009 Oct 6;73(14):1134-41
pubmed: 19805730
HNO. 2016 Aug;64(8):540-8
pubmed: 27259640
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762
Eur Arch Otorhinolaryngol. 2021 Oct;278(10):3725-3730
pubmed: 33095432
J Virol. 1990 Nov;64(11):5367-75
pubmed: 2170676
Can J Neurol Sci. 2022 Mar;49(2):184-195
pubmed: 33843530
EClinicalMedicine. 2020 Nov;28:100575
pubmed: 33083773
Ann N Y Acad Sci. 1999 May 28;871:221-31
pubmed: 10372074
Int Forum Allergy Rhinol. 2020 Oct;10(10):1127-1135
pubmed: 32761796
Chem Senses. 2020 Dec 5;45(9):865-874
pubmed: 33245136
Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3325-3332
pubmed: 33471170
Eur Arch Otorhinolaryngol. 2021 Apr;278(4):1233-1236
pubmed: 32875391
Otol Neurotol. 2019 Jan;40(1):88-95
pubmed: 30289843
Ear Nose Throat J. 2021 Jan;100(1):29-30
pubmed: 32931322
Neurology. 2005 Sep 27;65(6):898-904
pubmed: 16186531
Ear Nose Throat J. 2021 Nov;100(9):667-672
pubmed: 32339052
Front Public Health. 2020 Nov 05;8:592878
pubmed: 33251179
Dtsch Med Wochenschr. 2020 Jul;145(15):1074-1079
pubmed: 32731282